Mercator Medical S.A.
MRC.WA · WSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.14 | 0.09 | 0.08 | -0.03 |
| FCF Yield | 8.63% | -3.77% | -8.75% | -10.83% |
| EV / EBITDA | 22.75 | 218.44 | 10.95 | 3,390.70 |
| Quality | ||||
| ROIC | 0.05% | -1.42% | -0.11% | 2.42% |
| Gross Margin | 18.44% | 24.00% | 29.51% | 28.47% |
| Cash Conversion Ratio | 10.52 | -0.38 | -0.97 | -2.08 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.31% | 5.42% | 2.26% | -0.29% |
| Free Cash Flow Growth | 315.41% | 55.24% | 24.70% | -131.50% |
| Safety | ||||
| Net Debt / EBITDA | -8.21 | -61.91 | -4.49 | -1,222.56 |
| Interest Coverage | 1.28 | -25.31 | -11.66 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.62 | 0.52 | 0.45 | 0.48 |
| Cash Conversion Cycle | 196.65 | 245.43 | 236.58 | 176.88 |